SL-634

N/A

Report date: 2025/01/26 15:31:59

Base Information

Drug NameSL-634
Drug Alias Namebispecific VEGF/ANG2 surrobody (University of Colorado)SL-634
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionAngiopoietin-2 inhibitorsVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptorAngiopoietin-2
Therapy Area/IndicationsWet age-related macular degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Colorado System
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Colorado System
Inactive CompaniesN/A
Active IndicationsWet age-related macular degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A